Antibiotic News and Research

RSS
Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Drug companies developing novel treatments for MDR-TB

Drug companies developing novel treatments for MDR-TB

GeneXpert TB test maker Cepheid signs deals with PEPFAR, USAID, others to provide lower-cost kits

GeneXpert TB test maker Cepheid signs deals with PEPFAR, USAID, others to provide lower-cost kits

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

Healthcare professionals receive SingHealth Duke-NUS Scientific Congress abstract awards

BioDiem granted European patent for antimicrobial drug

BioDiem granted European patent for antimicrobial drug

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Boric acid treatment equals best practice for otitis media

Boric acid treatment equals best practice for otitis media

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

Shared decision-making tool cuts antibiotic use

Shared decision-making tool cuts antibiotic use

Shampoo effective for pruritus relief in dogs

Shampoo effective for pruritus relief in dogs

OrPro to advance development of ORP-100 for treatment of cystic fibrosis

OrPro to advance development of ORP-100 for treatment of cystic fibrosis

InSite Vision second quarter total revenues decrease to $1.8 million

InSite Vision second quarter total revenues decrease to $1.8 million

DECISION+2 can reduce antibiotic use for acute respiratory infections

DECISION+2 can reduce antibiotic use for acute respiratory infections

Combined approach reduces SSIs by 33% in patients after colorectal procedures

Combined approach reduces SSIs by 33% in patients after colorectal procedures

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance

Malaria misdiagnosis: an interview with Dr Toby Leslie

Malaria misdiagnosis: an interview with Dr Toby Leslie

Malaria commonly misdiagnosed and mistreated in Afghanistan

Malaria commonly misdiagnosed and mistreated in Afghanistan

WASC accredits Cedars-Sinai PhD program in biomedical sciences and translational medicine

WASC accredits Cedars-Sinai PhD program in biomedical sciences and translational medicine

New combination therapy for TB shows promise in Phase II study

New combination therapy for TB shows promise in Phase II study

Malaria misdiagnosis in parts of Asia

Malaria misdiagnosis in parts of Asia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.